{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T01:39:06Z","timestamp":1791855546830,"version":"4.3.4"},"reference-count":14,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2020,7,21]],"date-time":"2020-07-21T00:00:00Z","timestamp":1595289600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,7,21]],"date-time":"2020-07-21T00:00:00Z","timestamp":1595289600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Virchows Arch"],"published-print":{"date-parts":[[2021,4]]},"DOI":"10.1007\/s00428-020-02882-w","type":"journal-article","created":{"date-parts":[[2020,7,21]],"date-time":"2020-07-21T01:03:17Z","timestamp":1595293397000},"page":"801-804","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["ANCA-associated pauci-immune necrotizing glomerulonephritis during the treatment with pembrolizumab"],"prefix":"10.1007","volume":"478","author":[{"given":"Meral","family":"Uner","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bassam","family":"Alhasson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jagdeep","family":"Obhrai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9092-3313","authenticated-orcid":false,"given":"Serena M","family":"Bagnasco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,7,21]]},"reference":[{"key":"2882_CR1","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.ejca.2015.11.016","volume":"54","author":"JM Michot","year":"2016","unstructured":"Michot JM, Bigenwald C, Champiat S, Collins M, Carbonnel F, Postel-Vinay S, Berdelou A, Varga A, Bahleda R, Hollebecque A, Massard C, Fuerea A, Ribrag V, Gazzah A, Armand JP, Amellal N, Angevin E, Noel N, Boutros C, Mateus C, Robert C, Soria JC, Marabelle A, Lambotte O (2016) Immune-related adverse events with immune checkpoint blockade: a comprehensive review. Eur J Cancer 54:139\u2013148. https:\/\/doi.org\/10.1016\/j.ejca.2015.11.016","journal-title":"Eur J Cancer"},{"key":"2882_CR2","doi-asserted-by":"publisher","first-page":"2039","DOI":"10.1681\/ASN.2018050488","volume":"29","author":"MA Perazella","year":"2018","unstructured":"Perazella MA, Shirali AC (2018) Nephrotoxicity of cancer immunotherapies: past, present and future. J Am Soc Nephrol 29:2039\u20132052. https:\/\/doi.org\/10.1681\/ASN.2018050488","journal-title":"J Am Soc Nephrol"},{"key":"2882_CR3","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1053\/j.ajkd.2016.02.057","volume":"68","author":"AC Shirali","year":"2016","unstructured":"Shirali AC, Perazella MA, Gettinger S (2016) Association of acute interstitial nephritis with programmed cell death 1 inhibitor therapy in lung cancer patients. Am J Kidney Dis 68:287\u2013291. https:\/\/doi.org\/10.1053\/j.ajkd.2016.02.057","journal-title":"Am J Kidney Dis"},{"key":"2882_CR4","doi-asserted-by":"publisher","first-page":"1259","DOI":"10.2169\/internalmedicine.9814-17","volume":"57","author":"S Kishi","year":"2018","unstructured":"Kishi S, Minato M, Saijo A, Murakami N, Tamaki M, Matsuura M, Murakami T, Nagai K, Abe H, Nishioka Y, Doi T (2018) IgA nephropathy after nivolumab therapy for postoperative recurrence of lung squamous cell carcinoma. Intern Med 57:1259\u20131263. https:\/\/doi.org\/10.2169\/internalmedicine.9814-17","journal-title":"Intern Med"},{"key":"2882_CR5","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1053\/j.ajkd.2017.04.026","volume":"70","author":"A Kitchlu","year":"2017","unstructured":"Kitchlu A, Fingrut W, Avila-Casado C, Chan CT, Crump M, Hogg D, Reich HN (2017) Nephrotic syndrome with cancer immunotherapies: a report of 2 cases. Am J Kidney Dis 70:581\u2013585. https:\/\/doi.org\/10.1053\/j.ajkd.2017.04.026","journal-title":"Am J Kidney Dis"},{"key":"2882_CR6","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1016\/j.ekir.2018.10.017","volume":"4","author":"T Ashour","year":"2019","unstructured":"Ashour T, Nakhoul G, Patil P, Funchain P, Herlitz L (2019) Immune check point inhibitor-associated glomerulonephritis kidney. Int Rep 4:355\u2013359. https:\/\/doi.org\/10.1016\/j.ekir.2018.10.017","journal-title":"Int Rep"},{"key":"2882_CR7","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1186\/s12882-016-0408-2","volume":"17","author":"K Jung","year":"2016","unstructured":"Jung K, Zeng X, Bilusic M (2016) Nivolumab-associated acute glomerulonephritis: a case report and literature review. BMC Nephrol 17:188. https:\/\/doi.org\/10.1186\/s12882-016-0408-2","journal-title":"BMC Nephrol"},{"key":"2882_CR8","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1053\/j.ajkd.2019.04.016","volume":"74","author":"AJ Gallan","year":"2019","unstructured":"Gallan AJ, Alexander E, Reid P, Kutuby F, Chang A, Henriksen KJ (2019) Renal vasculitis and pauci-immune glomerulonephritis associated with immune checkpoint inhibitors. Am J Kidney Dis 74:853\u2013856. https:\/\/doi.org\/10.1053\/j.ajkd.2019.04.016","journal-title":"Am J Kidney Dis"},{"key":"2882_CR9","doi-asserted-by":"publisher","first-page":"e103","DOI":"10.1016\/j.jtho.2017.03.011","volume":"12","author":"MH Heo","year":"2017","unstructured":"Heo MH, Kim HK, Lee H, Ahn MJ (2017) Antineutrophil cytoplasmic antibody-associated rapid progressive glomerulonephritis after pembrolizumab treatment in thymic epithelial tumor: a case report. J Thorac Oncol 12:e103\u2013e105. https:\/\/doi.org\/10.1016\/j.jtho.2017.03.011","journal-title":"J Thorac Oncol"},{"key":"2882_CR10","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/s40425-018-0478-8","volume":"7","author":"O Mamlouk","year":"2019","unstructured":"Mamlouk O, Selamet U, Machado S, Abdelrahim M, Glass WF, Tchakarov A, Gaber L, Lahoti A, Workeneh B, Chen S, Lin J, Abdel-Wahab N, Tayar J, Lu H, Suarez-Almazor M, Tannir N, Yee C, Diab A, Abudayyeh A (2019) Nephrotoxicity of immune checkpoint inhibitors beyond tubulointerstitial nephritis: single-center experience. J Immunother Cancer 7:2. https:\/\/doi.org\/10.1186\/s40425-018-0478-8","journal-title":"J Immunother Cancer"},{"key":"2882_CR11","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.1093\/rheumatology\/kew063","volume":"55","author":"RR van den Brom","year":"2016","unstructured":"van den Brom RR, Abdulahad WH, Rutgers A, Kroesen BJ, Roozendaal C, de Groot DJ, Schroder CP, Hospers GA, Brouwer E (2016) Rapid granulomatosis with polyangiitis induced by immune checkpoint inhibition. Rheumatology (Oxford) 55:1143\u20131145. https:\/\/doi.org\/10.1093\/rheumatology\/kew063","journal-title":"Rheumatology (Oxford)"},{"key":"2882_CR12","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1097\/PPO.0000000000000296","volume":"24","author":"DY Wang","year":"2018","unstructured":"Wang DY, Johnson DB, Davis EJ (2018) Toxicities associated with PD-1\/PD-L1 blockade. Cancer J 24:36\u201340. https:\/\/doi.org\/10.1097\/PPO.0000000000000296","journal-title":"Cancer J"},{"key":"2882_CR13","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.currproblcancer.2016.12.004","volume":"41","author":"N Murakami","year":"2017","unstructured":"Murakami N, Motwani S, Riella LV (2017) Renal complications of immune checkpoint blockade. Curr Probl Cancer 41:100\u2013110. https:\/\/doi.org\/10.1016\/j.currproblcancer.2016.12.004","journal-title":"Curr Probl Cancer"},{"key":"2882_CR14","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1681\/ASN.2019070676","volume":"31","author":"FB Cortazar","year":"2020","unstructured":"Cortazar FB, Kibbelaar ZA, Glezerman IG, Abudayyeh A, Mamlouk O, Motwani SS, Murakami N, Herrmann SM, Manohar S, Shirali AC, Kitchlu A, Shirazian S, Assal A, Vijayan A, Renaghan AD, Ortiz-Melo DI, Rangarajan S, Malik AB, Hogan JJ, Dinh AR, Shin DS, Marrone KA, Mithani Z, Johnson DB, Hosseini A, Uprety D, Sharma S, Gupta S, Reynolds KL, Sise ME, Leaf DE (2020) Clinical features and outcomes of immune checkpoint inhibitor-associated AKI: a multicenter study. J Am Soc Nephrol 31:435\u2013446. https:\/\/doi.org\/10.1681\/ASN.2019070676","journal-title":"J Am Soc Nephrol"}],"container-title":["Virchows Archiv"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00428-020-02882-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00428-020-02882-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00428-020-02882-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,20]],"date-time":"2021-07-20T23:40:07Z","timestamp":1626824407000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00428-020-02882-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7,21]]},"references-count":14,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2021,4]]}},"alternative-id":["2882"],"URL":"https:\/\/doi.org\/10.1007\/s00428-020-02882-w","relation":{},"ISSN":["0945-6317","1432-2307"],"issn-type":[{"value":"0945-6317","type":"print"},{"value":"1432-2307","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,7,21]]},"assertion":[{"value":"7 May 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 June 2020","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 June 2020","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 July 2020","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}